Does X(a) mark the spot? An indirect mixed treatment comparison of Xa inhibitors compared to warfarin for patients with Atrial Fibrillation
ConclusionsThe Non-vitamin K antagonist oral anticoagulants constitute a new and promising category in the field of atrial fibrillation, even in the context of uncertainty, which an indirect comparison yields.
Source: Health Policy and Technology - Category: Health Management Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Gastroenterology | Health Management | Hemorrhagic Stroke | Pradaxa | Stroke | Study | Vitamin K | Vitamins | Warfarin